Technology

Trinity Consultants' acquisition of CEQA/NEPA expert Meridian is more than a regional deal; it's a strategic move with deep implications for biopharma.

J.P. Morgan's 2026 outlook reveals how private markets, fueled by AI, are rebuilding the physical backbone of the global supply chain.

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?

BDO USA's launch of a new government unit isn't just a merger. It's a strategic play to dominate the high-stakes world of public sector recovery.

A modest SEK 1.5 million order may not turn heads, but for Cell Impact, it's a critical validation that could unlock mass production in the booming Asian FCEV market.

Domestic manufacturing, massive power demands from AI and EVs, and a skilled labor shortage are converging to define a pivotal year for American industry.

GE Lighting's latest launch isn't just about new bulbs. It's a strategic play balancing sculptural design with scientific precision for the modern home.

A new military satellite project in the Arctic is about more than defence. It's a test for a new procurement model and a major bet on Canadian tech.

Hapag-Lloyd renews a key $550M funding facility, revealing a critical strategy for financial resilience in the turbulent global shipping industry.

A new patent for reactivated carbon technology offers a circular solution to destroy "forever chemicals," promising a reliable path for U.S. water safety.

Beyond transmissions, Allison's deep investment in India is a blueprint for global firms fueling defense, mining, and export growth. Here's why it matters.

How a social media-fueled cosmetics brand leveraged its whimsical aesthetic to land a major deal with Ulta, rewriting the playbook for digital-first success.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

New data reveals a shocking gap between perceived and actual workplace safety. Millions may be relying on luck as a culture of silence hides daily risks.

With its new 'Eagle Line' pilot facility online, QuantumScape takes a leap toward the EV future. We analyze the tech, the risks, and the competition.

CityHealth's 2025 report shows local policy is potent medicine. Discover how cities like Chicago are using data to tackle health, from housing to greenspace.

Netcapital's huge 1M share grant to its new CEO is a high-stakes play. We decode the strategy, the risk, and the ambitious revenue targets.

With its finances in distress, Netcapital bets its future on blockchain and a new CEO. Can a turnaround specialist navigate the crypto frontier?

The biotech is advancing a promising myelofibrosis therapy while developing a next-gen 'super drug,' a dual strategy signaling significant growth.

For the fifth year, GCM Grosvenor is a top workplace. We explore how their people-first strategy is a key asset in the competitive world of finance.